Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie O'Haire

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|December 24, 2024
The value of real world evidence and pragmatic trials in advanced prostate cancer- insights from the electronic Prostate Cancer Australian and Asian DatabaseAngelyn Anton, Kristina Zlatic, Sophie O'Haire, et al.
Public Health Genomics|March 11, 2025
Facilitating Equitable Access to Genomic Testing for Advanced Cancer: A Combined Intuition and Theory-Informed Approach to Intervention Development and DeploymentRona Weerasuriya, Joseph Elias, Melissa Martyn, et al.
Scientific Reports|November 28, 2022
A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumoursYoon-Jung Kang, Sophie O'Haire, Fanny Franchini, et al.
Scientific Reports|March 14, 2023
Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumoursSophie O'Haire, Fanny Franchini, Yoon-Jung Kang, et al.
Targeted Oncology|September 5, 2022
Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control ArmSophie O'Haire, Koen Degeling, Fanny Franchini, et al.
JCO Oncology Practice|May 28, 2024
Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway InhibitorsYing Yan Zhong, Angelyn Anton, Owen Xie, et al.
Therapeutic Advances in Medical Oncology|March 16, 2026
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapiesCiara Conduit, Bruno Valentin Sinn, Catherine Mitchell, et al.
Basic and Clinical Andrology|September 2, 2024
Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysisGrace Y Kim, Ciara Conduit, Sophie O'Haire, et al.
BJU International|July 24, 2024
Pseudoephedrine for ejaculatory dysfunction after retroperitoneal lymph node dissection in testicular cancerCiara Conduit, Jeremy Lewin, Wei Hong, et al.
JMIR Cancer|October 28, 2022
Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods StudyCiara Conduit, Christina Guo, Allan B Smith, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|December 24, 2024
The value of real world evidence and pragmatic trials in advanced prostate cancer- insights from the electronic Prostate Cancer Australian and Asian DatabaseAngelyn Anton, Kristina Zlatic, Sophie O'Haire, et al.
Public Health Genomics|March 11, 2025
Facilitating Equitable Access to Genomic Testing for Advanced Cancer: A Combined Intuition and Theory-Informed Approach to Intervention Development and DeploymentRona Weerasuriya, Joseph Elias, Melissa Martyn, et al.
Scientific Reports|November 28, 2022
A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumoursYoon-Jung Kang, Sophie O'Haire, Fanny Franchini, et al.
Scientific Reports|March 14, 2023
Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumoursSophie O'Haire, Fanny Franchini, Yoon-Jung Kang, et al.
Targeted Oncology|September 5, 2022
Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control ArmSophie O'Haire, Koen Degeling, Fanny Franchini, et al.
JCO Oncology Practice|May 28, 2024
Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway InhibitorsYing Yan Zhong, Angelyn Anton, Owen Xie, et al.
Therapeutic Advances in Medical Oncology|March 16, 2026
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapiesCiara Conduit, Bruno Valentin Sinn, Catherine Mitchell, et al.
Basic and Clinical Andrology|September 2, 2024
Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysisGrace Y Kim, Ciara Conduit, Sophie O'Haire, et al.
BJU International|July 24, 2024
Pseudoephedrine for ejaculatory dysfunction after retroperitoneal lymph node dissection in testicular cancerCiara Conduit, Jeremy Lewin, Wei Hong, et al.
JMIR Cancer|October 28, 2022
Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods StudyCiara Conduit, Christina Guo, Allan B Smith, et al.
Pageof 2